-
Identification and analysis of differential miRNA in exosomes of dopaminergic neurons overexpressing α-synuclein
-
Identification of Comprehensive PD Subtypes Using PPMI Study Data with Recurrent Neural Networks
-
Identification of gut microbial genes in Parkinson’s disease by shotgun metagenomic analysis
-
Identification of L-DOPA “on/off” states using speech-based analysis in Parkinson’s disease subjects
-
Identification of modifiers of the age of onset variance and disease progression in a Dutch cohort of Machado-Joseph disease patients
-
Identification of putative serum biomarkers for parkin-related Parkinson’s disease by metabolome analysis
-
Identifying delirium and it prevalence in idiopathic Parkinson’s disease
-
Identifying the neural correlates of doorway freezing in Parkinson’s disease
-
Identifying therapeutic targets from spontaneous beneficial brain lesions
-
Imaging Analysis of the International Tourette Syndrome Deep Brain Stimulation Registry and Database
-
Imaging neurodegeneration biomarkers in Essential Tremor
-
Immediate Effect of Elastic Taping on Balance and Postural Control in Early Parkinson’s Disease: A Pilot Study
-
Immediate effects of walking training with Honda Walking Assist Device on gait parameters of Parkinson’s disease
-
Immunological causes of atypical parkinsonism
-
Impact of a Parkinson’s Disease-Specific Order Set on Inpatient Medication Administration
-
Impact of Age on Levodopa dosage regimes in Idiopathic Parkinson’s Disease
-
Impact of changes in resistance on current delivered in constant voltage DBS stimulator in Parkinson’s Disease
-
Impact of Disease Duration and Anatomical Target on Health Related QoL in Patients Receiving DBS: Results from the Product Surveillance Registry
-
Impact of Dyskinesia in Parkinson’s Disease (PD) on Activities of Daily Living (ADLs) and Daily Tasks: Results from Pooled Phase 3 ADS-5102 Clinical Trials
-
Impact of electrode impedance changes in clinical outcomes of patients with Parkinson’s disease and subthalamic nucleus deep brain stimulation
-
Impact of injection guidance techniques on the efficacy and safety of incobotulinumtoxinA for sialorrhea
-
Impact of Late-onset REM Sleep Behavior Disorder on the Symptoms of Parkinson’s Disease
-
Impact of postural stability estimation in HY scale. (Pull test Vs. limits of stability assessment)
-
Impact of STN-DBS on Medication Reduction
-
Impact of Subthalamic Nucleus Stimulation on Striatal Dopamine Transporter in Parkinsonian Rat Models
-
Impact of SYN120 (a Dual 5-HT6/5-HT2A antagonist) on psychiatric symptoms in patients with Parkinson’s disease dementia: Results from a Phase 2a Study
-
Impact on the Quality of Life (CV) of people with Parkinson’s disease participating in community workshops of the public health system of Coquimbo, Chile
-
Impaired performance on measures of goal-directed behavior are associated with greater caregiver burden in Parkinson’s disease
-
Impaired reaching movements in idiopathic cervical dystonia patients
-
Impaired stopping reversed through dopamine replacement in Parkinson’s disease
-
Impaired topographic organization in cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson’s disease
-
Improved sleep structure after cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus
-
Improvement in chorea and function in a patient with dystonia-choreoathetosis cerebral palsy after treatment with bilateral pallidal deep brain stimulation
-
Improvement in Patient Perceived Quality of Life with DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia
-
Improvement of antisaccade amplitude by the STN DBS and target eccentricity
-
Improvement of Levodopa-Responsive Chronic Pain after STN-DBS in Parkinson’s disease
-
Improvements of tremor control and life quality of refractory essential tremor patients after MR-guided focused ultrasound thalamotomy – A Taiwan experience
-
Improving clinical data collection at patients’ home in Parkinson’s disease: The Sleep Fit app
-
Improving compliance to Parkinsonism’s pharmacotherapy amongst patients attending a Movement Disorders Clinic (MDC)
-
Impulse control disorders and compulsive behaviours in Parkinson’s disease. Results from the COPPADIS Study Cohort
-
Impulse control disorders could be accompanied by hypomanic state under intestinal levodopa infusion
-
Impulsive-Compulsive Behaviour disorders: A longitudinal study in de-novo in Parkinson’s disease patients
-
In vivo MRI signatures of hippocampal subfield pathology in patients with Parkinson’s disease and psychosis
-
In vivo staging of pathology in REM sleep behaviour disorder
-
Incidence of Parkinson’s disease: Pooled analysis of six high-quality incidence studies with long-term follow-up
-
Incidence, prevalence and clinical features of sleep disorders in alphasynucleinopthies: A cohort study
-
Incobotulinum toxin type A for the treatment of biceps/triceps co-contraction due to obstetrical brachial plexus lesion
-
Increased Parkin expression in a PARK20 (SYNJ1 mutation) iPSCs-based model
-
Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
-
Incremental hourly burden of “OFF” episodes on patient quality of life and health resource use among patients with Parkinson’s disease: A Neurologist/Patient Real World Assessment in the US
-
Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry
-
Influence of baseline OFF-time in the efficacy response of opicapone in Parkinson’s disease patients with motor fluctuations: The BIPARK-I double-blind experience
-
Influence of disease progression on the quality of life of individuals with spinocerebellar ataxia type 10
-
Influence of dopamine deficiency on interhemispheric crosstalk in Parkinson’s disease
-
Influence of Wearing Empty Backpack on Gait and Balance in Patients with Degenerative Parkinsonian syndrome
-
Inherited neuromyotonia associated with a dominant-negative KCNQ2 mutation
-
Inhibition of HDAC4 attenuates rotenone-induced abnormal increase of α-synuclein levels and affects autophagic flux in human dopaminergic SH-SY5Y cells
-
Inpatient care for Parkinson’s disease in Germany: Analysis of more than one million cases from the years 2010 to 2015
-
Instrumental assessment of upper extremity bradykinesia in UPDRS testing based on depth video data
-
Instrumented gait analysis identifies potential predictors for Parkinson’s disease converters
-
Insular atrophy as a marker of depression in Multiple System Atrophy: A voxel-based morphometry study
-
Insulin degrading enzyme, a novel key protein against alpha-synuclein oligomers formation?
-
Integrated Complimentary Yoga and Ayurveda Treatment Confers Significant Benefits in PD Patients
-
Integrated whole exome sequencing and chromosomal microarray in familial Parkinson’s disease
-
Intellectual disability with spastic ataxia: Atypical Infantile neuroaxonal dystrophy with absent spheroids
-
Intensive speech rehabilitation in degenerative ataxias improves intelligility
-
Interaction between MAPT H1 and APOE4 in early Parkinson’s Disease
-
Interaction between mGluR5 and NR2B is increased in 6-OHDA parkinsonian rats with L-dopa-induced dyskinesiaInteraction between mGluR5 and NR2B is increased in 6-OHDA parkinsonian rats with L-dopa-induced dyskinesia
-
Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synuclenopathies
-
Interaction of TDP-43 with IAPP in pancreatic beta cells of patients with sinucleinopathies
-
Intercultural differences in the frequency of impulsive control disorders in Parkinson’s disease
-
Interest in Genetic Testing in PD Patients with DBS
-
Internet of Things for Empowerment and Improved Treatment of Patients with Parkinson’s Disease
-
Interrater reliability of the Unified Huntington’s Disease Rating Scale-Total Motor Score certification
-
Intranasal Delivery of Bromocriptine loaded Lipid Nano Carriers for Enhanced Brain Delivery in Parkinson’s disease
-
Intranasal delivery of insulin for the restoration of memory signaling in Alzheimer disease
-
Intraoperative Electromyography can optimize pallidotomy for Parkinson’s disease and dystonias
-
Intraoperative local field potential recordings from deep brain stimulation electrodes help predict efficacy of subthalamic nucleus stimulation in patients with Parkinson’s disease
-
Intraparenchymal Cyst Formation: A Rare Complication of Deep Brain Stimulation
-
Intrastriatal Fyn silencing as a gene therapy strategy to manage levodopa induced dyskinesia in a mice model of Parkinson’s disease
-
Intrathecal baclofen (ITB) therapy in the treatment of severe spasticity: Safety and Product Performance from a Large Multinational Multi-Center Registry
-
INTREPID: A Prospective, Double Blinded, Multicenter Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant Current Rechargeable System in Parkinson’s disease
-
Intrinsic functional connectivity correlates of anxiety in cognitively unimpaired drug-naïve patients with Parkinson’s disease
-
Intronic pentanucleotide TTTCA repeat insertion in SAMD12 gene causes familial cortical myoclonic tremor with epilepsy type 1
-
Investigating the clinical predictors of depression in Huntington’s disease: An Enroll-HD Database Study
-
Investigating the influence of alpha-synuclein promoter (Rep1) polymorphism on cognition, disability and plasma alpha-synuclein levels in Parkinson’s disease
-
Investigating the role of microRNA biogenesis pathway in neuroprotection in primary neuronal culture model of Parkinson’s disease
-
Investigation of the incidences of non-motor symptoms in first-degree relatives and the spouses of patients with Parkinson’s disease
-
Investigation on the neural effects by differing the parameters of electrical stimulation for the relief of parkinsonian symptoms
-
Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy?
-
Is early onset ataxia phenotypically discernible from developmental disorders with impaired coordination?
-
Is Heart Rate variability a differential biomarker in REM sleep behavior disorder, Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy?
-
Is lowering stimulation frequency a feasible option to improve speech in Parkinson’s disease patients undergoing subthalamic deep brain stimulation?
-
Is primary writing tremor a form fruste of dystonia?
-
Is REM sleep behavior disorder associated with excessive daytime sleepiness in military veterans with Parkinson’s disease?
-
Is repetitive transcranial magnetic stimulation an effective tool to treat pain in Parkinson’s Disease?
-
Is safinamide useful for atypical Parkinsonian syndromes?
-
Is there a relationship between depression/anxiety and physical inactivity in Parkinson Disease?
-
Is there a role for miRNA in the diagnosis of PD?
-
It takes two to tango but following may be more beneficial for rehabilitating people with mild-moderate Parkinson’s
-
Item Response Theory Analysis of the Unified Dyskinesia Rating Scale Items
2018 International Congress
October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.